Therapeutics News and Research

RSS

Lessons for COVID-19 from 2009 H1N1

The world has experienced many outbreaks of viral diseases. Over the past two decades, we have also seen the emergence of zoonotic human respiratory coronaviruses with pandemic potential.

13 May 2020

New treatment improves survival for people with common liver cancer

For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.

13 May 2020

Trial E3311: Less intense treatment for HPV+ oropharynx cancer shows positive results

The final results of the randomized phase two trial E3311 will be presented at the American Society of Clinical Oncology annual meeting, to occur virtually from May 29-31.

13 May 2020

UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients

UCI Health will initiate a clinical study of a drug to treat critically ill COVID-19 patients who face a high mortality rate because of acute inflammation that fills their lungs with fluid, a grave condition that even mechanical ventilation cannot improve.

13 May 2020

Researchers make a significant leap in mucus biology

Worldwide, hundreds of millions of people are impacted by chronic respiratory disease. COPD alone affects more than 250 million people, causing 3 million deaths each year.

13 May 2020

Research examines molecules derived from ticks as potential COVID-19 treatment option

UK-based biotechnology firm ILC Therapeutics is working alongside the University of Oxford to examine the use of Evasins – molecules derived from ticks – as a potential COVID-19 treatment option for patients whose lungs are badly damaged by the virus and face a critical juncture in recovery.

13 May 2020

U.S. physician survey highlights impact and burden of Thyroid Eye Disease on patients’ quality of life

Horizon Therapeutics plc today announced results of a U.S. physician survey showing that endocrinologists and ophthalmologists perceive Thyroid Eye Disease to have a significant burden on their patients’ quality of life.

13 May 2020

USP launches new program to accelerate the development of effective COVID-19 treatments

To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia has launched a new program to support scientists, developers and manufacturers worldwide.

13 May 2020

Could JAK blockers help treat COVID-19?

A new study published in the journal Science Immunology in May 2020 reports that compounds that safely inhibit the JAK protein could be useful in treating COVID-19.

12 May 2020

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.

12 May 2020

COVID-19 patients improve after experimental heart cell therapy

Four of six critically ill COVID-19 (coronavirus) patients significantly improved after receiving an experimental therapeutic designed to reduce inflammation, a major cause of death from this disease, according to a case series published by Cedars-Sinai and Capricor Therapeutics.

12 May 2020

SARS-CoV-2 binds heparan sulfate, preventing host cell infection

A new study published in May 2020 on the preprint server bioRxiv shows that the SARS-CoV-2 virus can bind to a sugar molecule called heparan sulfate (HS), thereby hindering its entry into the host cell.

12 May 2020

Study reveals the effect of ancestry on molecular makeup of cancer

Questions about the genealogical imprint of tumors have hovered over cancer research since the completion of the Human Genome Project in 2003.

11 May 2020

Telehealth during COVID-19 could help avoid admissions for diabetic ketoacidosis

A new study has shown that for some patients with type 1 diabetes the close monitoring of their condition using telehealth protocols combined with appropriate technology may lead to better care during the COVID-19 pandemic, when patients are avoiding in-person visits.

11 May 2020

GCS centers support research to fight against global COVID-19 pandemic

In December 2019, the world learned of a new and deadly pathogen. News coming out of Wuhan, China confirmed public health experts' worst fears--a novel coronavirus appeared to have jumped from animals to humans.

11 May 2020

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.

11 May 2020

Study shows COVID-19 vulnerability is highly dependent on host genetic architecture

A new US study available on the preprint server medRxiv reveals certain genetic variations that are associated with infection susceptibility and diverse clinical presentation of coronavirus disease (COVID-19) – including asymptomatic cases and severe forms of the disease in younger patients.

10 May 2020

Therapeutics News and Research

Lessons for COVID-19 from 2009 H1N1

New treatment improves survival for people with common liver cancer

Trial E3311: Less intense treatment for HPV+ oropharynx cancer shows positive results

UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients

Researchers make a significant leap in mucus biology

Research examines molecules derived from ticks as potential COVID-19 treatment option

U.S. physician survey highlights impact and burden of Thyroid Eye Disease on patients’ quality of life

USP launches new program to accelerate the development of effective COVID-19 treatments

Could JAK blockers help treat COVID-19?

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

COVID-19 patients improve after experimental heart cell therapy

SARS-CoV-2 binds heparan sulfate, preventing host cell infection

Study reveals the effect of ancestry on molecular makeup of cancer

Telehealth during COVID-19 could help avoid admissions for diabetic ketoacidosis

GCS centers support research to fight against global COVID-19 pandemic

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Study shows COVID-19 vulnerability is highly dependent on host genetic architecture

Tissue engineering can play an important role during COVID-19 pandemic

Study finds race-specific lupus nephritis biomarkers for early diagnosis, treatment

OXGENE™ reports third consecutive year of 100% year on year revenue growth

Understanding the DNA Damage Response in Innate Immunity eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News